Micro Cap · Healthcare · Pharmaceutical Retailers
Micro Cap · Healthcare · Pharmaceutical Retailers
Get the AI take on PETS
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
45/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Forward P/E
Middle ground · 6% above avg
24.33x
Price / sales
Strong · Priced modestly against the revenue it brings in
0.23x
Price / FCF
No signal · Not enough data to judge
-
EV / EBITDA
No signal · Not enough data to judge
-
ROIC
Weak · Struggling to earn much on the capital it uses
-301.8%
ROE
Needs attention · Unfavorable
-78.6%
Debt / equity
Favorable · 0.02 - strong leverage
0.02x
Current ratio
Weak · Not enough on hand to cover near-term bills
0.68x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $39.56M | - | -20.3% | 45 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |